Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric J H Meuleman

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Asian Journal of Andrology|May 9, 2007
Application of correlation techniques in the analysis of corpus cavernosum electromyographic signalsXiao-Gang Jiang, Jan Holsheimer, Ljubomir Manola, et al.
Journal of Andrology|April 6, 2004
Evaluation of ICSI-selected epididymal sperm samples of obstructive azoospermic males by the CKIA systemLiliana Ramos, Peter De Boer, Eric J H Meuleman, et al.
The Journal of Sexual Medicine|January 23, 2010
Recommendations for the clinical evaluation of men and women with sexual dysfunctionDimitrios Hatzichristou, Raymond C Rosen, Leonard R Derogatis, et al.
Fertility and Sterility|June 13, 2003
Fertility in men with testicular germ cell tumorsJ Roan Spermon, Lambertus A L M Kiemeney, Eric J H Meuleman, et al.
Urologic Oncology|August 28, 2014
Risk of disease flare with LHRH agonist therapy in men with prostate cancer: myth or fact?André N Vis, Tim M van der Sluis, Hoda H M Al-Itejawi, et al.
European Journal of Endocrinology|February 13, 2009
Oral testosterone replacement in symptomatic late-onset hypogonadism: effects on rating scales and general safety in a randomized, placebo-controlled studyJean-Jacques Legros, Eric J H Meuleman, Jolanda M H Elbers, et al.
BMC Urology|June 3, 2014
Development of an in vitro model to measure bioactivity of botulinum neurotoxin A in rat bladder muscle stripsJanneke I M van Uhm, Goedele M A Beckers, Willem J van der Laarse, et al.
BJU International|October 14, 2011
Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancerTim M van der Sluis, André N Vis, R Jeroen A van Moorselaar, et al.
BJU International|October 14, 2011
Intraprostatic testosterone and dihydrotestosterone. Part II: concentrations after androgen hormonal manipulation in men with benign prostatic hyperplasia and prostate cancerTim M van der Sluis, Eric J H Meuleman, R Jeroen A van Moorselaar, et al.
Urology|March 8, 2013
Relationship between body mass index and serum testosterone concentration in patients receiving luteinizing hormone-releasing hormone agonist therapy for prostate cancerTim M van der Sluis, R Jeroen A van Moorselaar, Eric J H Meuleman, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Asian Journal of Andrology|May 9, 2007
Application of correlation techniques in the analysis of corpus cavernosum electromyographic signalsXiao-Gang Jiang, Jan Holsheimer, Ljubomir Manola, et al.
Journal of Andrology|April 6, 2004
Evaluation of ICSI-selected epididymal sperm samples of obstructive azoospermic males by the CKIA systemLiliana Ramos, Peter De Boer, Eric J H Meuleman, et al.
The Journal of Sexual Medicine|January 23, 2010
Recommendations for the clinical evaluation of men and women with sexual dysfunctionDimitrios Hatzichristou, Raymond C Rosen, Leonard R Derogatis, et al.
Fertility and Sterility|June 13, 2003
Fertility in men with testicular germ cell tumorsJ Roan Spermon, Lambertus A L M Kiemeney, Eric J H Meuleman, et al.
Urologic Oncology|August 28, 2014
Risk of disease flare with LHRH agonist therapy in men with prostate cancer: myth or fact?André N Vis, Tim M van der Sluis, Hoda H M Al-Itejawi, et al.
European Journal of Endocrinology|February 13, 2009
Oral testosterone replacement in symptomatic late-onset hypogonadism: effects on rating scales and general safety in a randomized, placebo-controlled studyJean-Jacques Legros, Eric J H Meuleman, Jolanda M H Elbers, et al.
BMC Urology|June 3, 2014
Development of an in vitro model to measure bioactivity of botulinum neurotoxin A in rat bladder muscle stripsJanneke I M van Uhm, Goedele M A Beckers, Willem J van der Laarse, et al.
BJU International|October 14, 2011
Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancerTim M van der Sluis, André N Vis, R Jeroen A van Moorselaar, et al.
BJU International|October 14, 2011
Intraprostatic testosterone and dihydrotestosterone. Part II: concentrations after androgen hormonal manipulation in men with benign prostatic hyperplasia and prostate cancerTim M van der Sluis, Eric J H Meuleman, R Jeroen A van Moorselaar, et al.
Urology|March 8, 2013
Relationship between body mass index and serum testosterone concentration in patients receiving luteinizing hormone-releasing hormone agonist therapy for prostate cancerTim M van der Sluis, R Jeroen A van Moorselaar, Eric J H Meuleman, et al.
Pageof 4